US2007191892A1PendingUtilityA1

Apparatus and methods for automatic adjustment of av interval to ensure delivery of cardiac resynchronization therapy

Individually held — no corporate assignee on recordPriority: Feb 3, 2006Filed: Feb 5, 2007Published: Aug 16, 2007
Est. expiryFeb 3, 2026(expired)· nominal 20-yr term from priority
A61N 1/3684A61N 1/36843A61N 1/3682A61N 1/36842A61N 1/3627
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The disclosure provides methods and apparatus of left ventricular pacing including automated adjustment of a atrio-ventricular (AV) pacing delay interval and intrinsic AV nodal conduction testing. It includes—upon expiration or reset of a programmable AV Evaluation Interval (AVEI)—performing the following: temporarily increasing a paced AV interval and a sensed AV interval and testing for adequate AV conduction and measuring an intrinsic atrio-ventricular (PR) interval for a right ventricular (RV) chamber. Thus, in the event that the AV conduction test reveals a physiologically acceptable intrinsic PR interval then storing the physiologically acceptable PR interval in a memory structure (e.g., a median P-R from one or more cardiac cycles). In the event that the AV conduction test reveals an AV conduction block condition or if unacceptably long PR intervals are revealed then a pacing mode-switch to a bi-ventricular (Bi-V) pacing mode occurs and the magnitude of the AVEI is increased.

Claims

exact text as granted — not AI-modified
1 . A method of left ventricular pacing including automated adjustment of a atrio-ventricular (AV) pacing delay interval and intrinsic AV nodal conduction testing comprising—upon expiration or reset of a programmable AV Evaluation Interval (AVEI)—performing the following steps: 
 temporarily increasing a paced AV (PAV) interval and a sensed AV (SAV) interval and a. testing for adequate AV conduction and b. measuring a median intrinsic atrio-ventricular (PR) interval for a first-to-depolarize ventricular chamber for at least three consecutive cardiac cycles, storing:    in the event that the AV conduction test reveals a physiologically acceptable intrinsic PR interval for said ventricular chamber then storing the physiologically acceptable median PR interval in a memory structure;    subtracting approximately 30 milliseconds from the median PR interval to define a pre-excitation interval (PEI);    in the event that the AV conduction test reveals unacceptably long PR intervals then: 1. performing a pacing mode-switch to a bi-ventricular (Bi-V) pacing mode and 2. increasing the magnitude of the AVEI; and    delivering a pacing stimulus to the last to depolarize ventricle approximately at the expiration of the PEI.    
   
   
       2 . A method according to  claim 1 , further comprising calculating an FAV delay interval for paced atrial events (F-PAV interval) and for sensed atrial events (F-SAV interval) and storing at least one of the F-PAV interval and the F-SAV interval in a first-in-first-out memory buffer.  
   
   
       3 . A method according to  claim 1 , further comprising: 
 delivering a single pacing stimulus to a left ventricular (LV) chamber at the expiration of the FAV delay interval.    
   
   
       4 . A method according to  claim 1 , wherein the AVEI comprises one of a temporal unit and a number of cardiac cycles.  
   
   
       5 . A method according to  claim 1 , wherein the AVEI expires or is adjusted based upon one of: a detected level of activity of a patient, a heart rate of the patient, a rate of change of the heart rate of the patient.  
   
   
       6 . A method according to  claim 2 , wherein the step of calculating an FAV delay interval for paced atrial events is based on the SAV interval is performed according to the mathematical relationship:  
         A   sp   CO =( A   p - RV   s )−( A   s - RV   s )  
     wherein A sp CO stands for an Atrial Sense/Atrial Pace Conduction Offset value.  
   
   
       7 . A method according to  claim 6 , further comprising periodically updating the A sp CO value.  
   
   
       8 . A method according to  claim 1 , further comprising: 
 immediately halting the performance of the claimed method based on satisfaction of one of a preselected criteria and predetermined condition; and    performing a pacing mode-switch to a bi-ventricular (Bi-V) pacing therapy.    
   
   
       9 . A method according to  claim 8 , wherein one of the preselected criteria and the predetermined condition comprises: a detection of a tachycardia episode, an occurrence of the tachycardia episode, a probability of the tachycardia episode, a detection of an arrhythmia, an AV conduction block condition, a prolonged AV conduction condition.  
   
   
       10 . A method according to  claim 9 , wherein the tachycardia episode comprises one of a ventricular tachycardia episode and a ventricular fibrillation episode.  
   
   
       11 . A method according to  claim 8 , wherein subsequent to one of the preselected criteria and the predetermined condition being satisfied waiting for a nominal interval and then performing at least one of the following: 
 performing the method of  claim 1  without utilizing any prior temporal values;    delay at least one AVEI and attempt to perform the method of  claim 1;     in the event that a programmable period of time has expired, then switching to Bi-V pacing therapy; and    adjusting a PVARP blanking interval for a programmable period of time.    
   
   
       12 . A method according to  claim 1 , further comprising: 
 wherein one of the rate of change and the magnitude of change from a prior FAV delay interval to a new FAV delay interval are constrained to a programmable increment.    
   
   
       13 . A method according to  claim 12 , wherein the programmable increment comprises between about five milliseconds and about thirty milliseconds.  
   
   
       14 . A method according to  claim 1 , further comprising: delivering a ventricular pacing pulse following a predetermined period of time during the AV conduction test.  
   
   
       15 . A method according to  claim 14 , wherein the pacing pulse is delivered at approximately 350 ms following detection of an atrial event.

Join the waitlist — get patent alerts

Track US2007191892A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.